Blood pressure, waist circumference, lipid profile, except for HDL, u-ACR, the use of angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor blocker (ARB), angiographic data and the prevalence of dyslipidemia and cerebrovascular disease were not significantly different across quartiles. This evidence concerns the gene ACE and cerebrovascular disorder.